175 related articles for article (PubMed ID: 11050643)
41. Ferumoxtran-10 MR lymphography for target definition and follow-up in a patient undergoing image-guided, dose-escalated radiotherapy of lymph nodes upon PSA relapse.
Weidner AM; van Lin EN; Dinter DJ; Rozema T; Schoenberg SO; Wenz F; Barentsz JO; Lohr F
Strahlenther Onkol; 2011 Mar; 187(3):206-12. PubMed ID: 21347637
[TBL] [Abstract][Full Text] [Related]
42. T1 and T2 relaxivity of intracellular and extracellular USPIO at 1.5T and 3T clinical MR scanning.
Simon GH; Bauer J; Saborovski O; Fu Y; Corot C; Wendland MF; Daldrup-Link HE
Eur Radiol; 2006 Mar; 16(3):738-45. PubMed ID: 16308692
[TBL] [Abstract][Full Text] [Related]
43. Lymph node metastases from head and neck squamous cell carcinoma: MR imaging with ultrasmall superparamagnetic iron oxide particles (Sinerem MR) -- results of a phase-III multicenter clinical trial.
Sigal R; Vogl T; Casselman J; Moulin G; Veillon F; Hermans R; Dubrulle F; Viala J; Bosq J; Mack M; Depondt M; Mattelaer C; Petit P; Champsaur P; Riehm S; Dadashitazehozi Y; de Jaegere T; Marchal G; Chevalier D; Lemaitre L; Kubiak C; Helmberger R; Halimi P
Eur Radiol; 2002 May; 12(5):1104-13. PubMed ID: 11976854
[TBL] [Abstract][Full Text] [Related]
44. MR lymphography: study of a high-efficiency lymphotrophic agent.
Weissleder R; Heautot JF; Schaffer BK; Nossiff N; Papisov MI; Bogdanov A; Brady TJ
Radiology; 1994 Apr; 191(1):225-30. PubMed ID: 8134576
[TBL] [Abstract][Full Text] [Related]
45. Atorvastatin and uptake of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) in human monocyte-macrophages: implications for magnetic resonance imaging.
Müller K; Skepper JN; Tang TY; Graves MJ; Patterson AJ; Corot C; Lancelot E; Thompson PW; Brown AP; Gillard JH
Biomaterials; 2008 Jun; 29(17):2656-62. PubMed ID: 18377983
[TBL] [Abstract][Full Text] [Related]
46. Ultrasmall superparamagnetic iron-oxide-enhanced MR imaging of normal bone marrow in rodents: original research original research.
Simon GH; Raatschen HJ; Wendland MF; von Vopelius-Feldt J; Fu Y; Chen MH; Daldrup-Link HE
Acad Radiol; 2005 Sep; 12(9):1190-7. PubMed ID: 16099684
[TBL] [Abstract][Full Text] [Related]
47. MR lymphography with iron oxide compound AMI-227: studies in ferrets with filariasis.
Tanoura T; Bernas M; Darkazanli A; Elam E; Unger E; Witte MH; Green A
AJR Am J Roentgenol; 1992 Oct; 159(4):875-81. PubMed ID: 1529857
[TBL] [Abstract][Full Text] [Related]
48. Visualization of lymphatic basin from the tumor using magnetic resonance lymphography with superparamagnetic iron oxide in patients with thoracic esophageal cancer.
Ishiyama K; Motoyama S; Tomura N; Sashi R; Imano H; Ogawa J; Narita K; Watarai J
J Comput Assist Tomogr; 2006; 30(2):270-5. PubMed ID: 16628046
[TBL] [Abstract][Full Text] [Related]
49. Physical and biological characterization of superparamagnetic iron oxide- and ultrasmall superparamagnetic iron oxide-labeled cells: a comparison.
Sun R; Dittrich J; Le-Huu M; Mueller MM; Bedke J; Kartenbeck J; Lehmann WD; Krueger R; Bock M; Huss R; Seliger C; Gröne HJ; Misselwitz B; Semmler W; Kiessling F
Invest Radiol; 2005 Aug; 40(8):504-13. PubMed ID: 16024988
[TBL] [Abstract][Full Text] [Related]
50. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging.
Deserno WM; Harisinghani MG; Taupitz M; Jager GJ; Witjes JA; Mulders PF; Hulsbergen van de Kaa CA; Kaufmann D; Barentsz JO
Radiology; 2004 Nov; 233(2):449-56. PubMed ID: 15375228
[TBL] [Abstract][Full Text] [Related]
51. Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro.
Metz S; Bonaterra G; Rudelius M; Settles M; Rummeny EJ; Daldrup-Link HE
Eur Radiol; 2004 Oct; 14(10):1851-8. PubMed ID: 15249981
[TBL] [Abstract][Full Text] [Related]
52. MR imaging of mediastinal lymph nodes: evaluation using a superparamagnetic contrast agent.
Pannu HK; Wang KP; Borman TL; Bluemke DA
J Magn Reson Imaging; 2000 Dec; 12(6):899-904. PubMed ID: 11105028
[TBL] [Abstract][Full Text] [Related]
53. Comparison of iron oxide particles (AMI 227) with a gadolinium complex (Gd-DOTA) in dynamic susceptibility contrast MR imagings (FLASH and EPI) for both phantom and rat brain at 1.5 Tesla.
Loubeyre P; De Jaegere T; Bosmans H; Miao Y; Ni Y; Landuyt W; Marchal G
J Magn Reson Imaging; 1999 Mar; 9(3):447-53. PubMed ID: 10194716
[TBL] [Abstract][Full Text] [Related]
54. AMI-227-enhanced MR lymphography: usefulness for differentiating reactive from tumor-bearing lymph nodes.
Vassallo P; Matei C; Heston WD; McLachlan SJ; Koutcher JA; Castellino RA
Radiology; 1994 Nov; 193(2):501-6. PubMed ID: 7972768
[TBL] [Abstract][Full Text] [Related]
55. Magnetic resonance lymphography. Enhancement patterns using superparamagnetic nanoparticles.
Clément O; Guimaraes R; de Kerviler E; Frija G
Invest Radiol; 1994 Jun; 29 Suppl 2():S226-8. PubMed ID: 7928239
[No Abstract] [Full Text] [Related]
56. Magnetic resonance imaging of experimental atherosclerotic plaque: comparison of two ultrasmall superparamagnetic particles of iron oxide.
Herborn CU; Vogt FM; Lauenstein TC; Dirsch O; Corot C; Robert P; Ruehm SG
J Magn Reson Imaging; 2006 Aug; 24(2):388-93. PubMed ID: 16791857
[TBL] [Abstract][Full Text] [Related]
57. Differential uptake of ferumoxtran-10 and ferumoxytol, ultrasmall superparamagnetic iron oxide contrast agents in rabbit: critical determinants of atherosclerotic plaque labeling.
Yancy AD; Olzinski AR; Hu TC; Lenhard SC; Aravindhan K; Gruver SM; Jacobs PM; Willette RN; Jucker BM
J Magn Reson Imaging; 2005 Apr; 21(4):432-42. PubMed ID: 15779033
[TBL] [Abstract][Full Text] [Related]
58. Magnetic resonance lymphography: a novel technique for lymph node assessment in gynecologic malignancies.
Narayanan P; Iyngkaran T; Sohaib SA; Reznek RH; Rockall AG
Cancer Biomark; 2009; 5(2):81-8. PubMed ID: 19414925
[TBL] [Abstract][Full Text] [Related]
59. Lymph node metastasis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging versus PET/CT in a rabbit model.
Choi SH; Moon WK; Hong JH; Son KR; Cho N; Kwon BJ; Lee JJ; Chung JK; Min HS; Park SH
Radiology; 2007 Jan; 242(1):137-43. PubMed ID: 17090719
[TBL] [Abstract][Full Text] [Related]
60. Contrast-enhanced MR imaging of liver and spleen: first experience in humans with a new superparamagnetic iron oxide.
Hamm B; Staks T; Taupitz M; Maibauer R; Speidel A; Huppertz A; Frenzel T; Lawaczeck R; Wolf KJ; Lange L
J Magn Reson Imaging; 1994; 4(5):659-68. PubMed ID: 7981510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
